PROLONGED ACCEPTANCE OF CONCORDANT AND DISCORDANT XENOGRAFTS WITH COMBINED CD40 AND CD28 PATHWAY BLOCKADE1
Eric T. Elwood(Emory University), Thomas C. Pearson(Emory Healthcare), Carol Tucker‐Burden(Emory University), Matthias Corbascio(Lund University), Christian P. Larsen(Emory University Hospital), Peter S. Linsley(Rosetta Stone (United States)), Alejandro Aruffo(University of Washington Medical Center), Hong Rae Cho(Emory University), Kevin J. Winn(Emory University), Shannon C. Ritchie(Emory University), Diane Z. Alexander(Emory University), Diane Hollenbaugh(Neoleukin Therapeutics (United States))
Cited by 119
Related Papers
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
|Cell|1993|824
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802